Niclosamide Suppresses Cancer Cell Growth By Inducing Wnt Co-Receptor LRP6 Degradation and Inhibiting the Wnt/Î²-Catenin Pathway
MetadataShow full item record
AbstractThe Wnt/b-catenin signaling pathway is important for tumor initiation and progression. The low density lipoprotein receptor-related protein-6 (LRP6) is an essential Wnt co-receptor for Wnt/b-catenin signaling and represents a promising anticancer target. Recently, the antihelminthic drug, niclosamide was found to inhibit Wnt/b-catenin signaling, although the mechanism was not well defined. We found that niclosamide was able to suppress LRP6 expression and phosphorylation, block Wnt3A-induced b-catenin accumulation, and inhibit Wnt/b-catenin signaling in HEK293 cells. Furthermore, the inhibitory effects of niclosamide on LRP6 expression/phosphorylation and Wnt/b-catenin signaling were conformed in human prostate PC-3 and DU145 and breast MDA-MB-231 and T-47D cancer cells. Moreover, we showed that the mechanism by which niclosamide suppressed LRP6 resulted from increased degradation as evident by a shorter half-life. Finally, we demonstrated that niclosamide was able to induce cancer cell apoptosis, and displayed excellent anticancer activity with IC50 values less than 1 mM for prostate PC-3 and DU145 and breast MDA-MB-231 and T-47D cancer cells. The IC50 values are comparable to those shown to suppress the activities of Wnt/b-catenin signaling in prostate and breast cancer cells. Our data indicate that niclosamide is a unique small molecule Wnt/b-catenin signaling inhibitor targeting the Wnt co-receptor LRP6 on the cell surface, and that niclosamide has a potential to be developed a novel chemopreventive or therapeutic agent for human prostate and breast cancer.
CitationPLoS One. 2011 Dec 16; 6(12):e29290
- Rottlerin induces Wnt co-receptor LRP6 degradation and suppresses both Wnt/β-catenin and mTORC1 signaling in prostate and breast cancer cells.
- Authors: Lu W, Lin C, Li Y
- Issue date: 2014 Jun
- Silibinin inhibits Wnt/β-catenin signaling by suppressing Wnt co-receptor LRP6 expression in human prostate and breast cancer cells.
- Authors: Lu W, Lin C, King TD, Chen H, Reynolds RC, Li Y
- Issue date: 2012 Dec
- Salinomycin suppresses LRP6 expression and inhibits both Wnt/β-catenin and mTORC1 signaling in breast and prostate cancer cells.
- Authors: Lu W, Li Y
- Issue date: 2014 Oct
- Niclosamide sensitizes triple-negative breast cancer cells to ionizing radiation in association with the inhibition of Wnt/β-catenin signaling.
- Authors: Yin L, Gao Y, Zhang X, Wang J, Ding D, Zhang Y, Zhang J, Chen H
- Issue date: 2016 Jul 5
- Gigantol inhibits Wnt/β-catenin signaling and exhibits anticancer activity in breast cancer cells.
- Authors: Yu S, Wang Z, Su Z, Song J, Zhou L, Sun Q, Liu S, Li S, Li Y, Wang M, Zhang GQ, Zhang X, Liu ZJ, Lu D
- Issue date: 2018 Feb 14
Showing items related by title, author, creator and subject.
Notch3 Signaling Mediates Heterotypic Cell Interactions During Blood Vessel FormationLiu, Hua; Vascular Biology Center (2010-11)Blood vessel formation is essential for embryogenesis, wound healing, menstruation, and pregnancy [1, 2]. While much emphasis has been placed on understanding the initial event of endothelial-tube formation, relatively little attention has been paid to the interactions of endothelial cells and the surrounding mural cells (pericytes, smooth muscle cells and fibroblasts). Increasing evidence suggests that the communication of endothelial cells and mural cells is crucial for the assembly, subsequent maturation, and stabilization of blood vessels [3-5]. Abnormal interactions between these two cell types have been implicated in many pathological conditions, including tumor angiogenesis, diabetic microangiopathy, tissue calcification and stroke. However, the molecules mediating the heterotypic interaction are still largely unknown. Our previous studies have shown that in a three-dimensional (3-D) angiogenesis assay, mural cells enhance blood vessel formation and directly interact with endothelial cells . During this process, Notch3 is one gene that is strongly induced in mural cells upon coculture with endothelial cells . Notch3, the causative gene of the neurovascular disorder CADASIL , belongs to an evolutionarily conserved family of transmembrane receptors that are known to govern cell fate determination in diverse cell types . Given that Notch receptors and ligands are expressed on both endothelial and mural cells and - 2 - Notch3 is upregulated in mural cells by coculturing with endothelial cells, it is reasonable to assume that the Notch3 receptor might regulate the association of endothelial and mural cells through receptor-ligand interaction during blood vessel formation. The goal of my thesis is to investigate how Notch3 gene expression is regulated in mural cells by endothelial cells and whether the Notch3 receptor is involved in the communication between endothelial and mural cells during blood vessel formation. To achieve these goals, three aims were proposed: Specific Aim 1: To define how Notch3 expression in mural cells is upregulated by endothelial cells. Specific Aim 2: To determine if endothelial cell-induced Notch3 expression is critical for mural cell differentiation. Specific Aim 3: To determine whether Notch3 expression in mural cells modulates blood vessel formation under both physiological and pathological conditions.
Hydroxyurea induces fetal hemoglobin expression by activating cAMP signaling pathways in a cAMP- and cGMP-dependent mannerIkuta, Tohru; Gutsaeva, Diana R.; Parkerson, James B.; Yerigenahally, Shobha D; Head, C. Alvin; Department of Anesthesiology and Perioperative Medicine (American Society of Hematology, 2010-12)Here we show that hydroxyurea (HU) induces fetal hemoglobin (HbF) expression by activating the cAMP pathway through two independent mechanisms. Although HU increased both cAMP and cGMP levels in CD34+-derived erythroblasts, only the cAMP pathway was found to be activated. However, HU-induced HbF expression was affected by the activities of both adenylate cyclase (AC) and soluble guanylate cyclase (sGC). HU decreased the expression of cGMP-inhibitable phosphodiesterase (PDE) 3B in a sGC-dependent manner, resulting in activation of the cAMP pathway. Second, HU induced the expression of cyclooxygenase-1 (COX-1) and increased the production of prostaglandin E2 (PGE2), which resulted in activation of the cAMP signaling pathway through AC. HU therapy elevated plasma PGE2 levels in sickle cell patients. These results demonstrate that HU induces HbF expression by activating the cAMP pathway via dual signaling mechanisms.
RGS protein modulation of neuronal Gaq-mediated signalingClark, Michael A.; Department of Pharmacology and Toxicology (2006-05)The decay of excitatory postsynaptic potentials (EPSPs) in neurons is much shorter than the predicted lifetime of activated G aq and thus GTPase activating proteins (GAPs) are thought to accelerate inactivation. PLCp and regulators of G-protein signaling (RGS) proteins act as GAPs toward G aq in vitro. Thus, it is unknown which of these GAPs determine the fast decay rate observed in neuronal EPSP termination. We therefore test the hypothesis that endogenous RGS proteins regulate the kinetics of Gaqmediated signaling in cultured rat cerebellar granule neurons (CGNs). Electrophysiological recordings of G aq-regulated standing outward potassium currents (Ik(SO>) were performed using mutant RGS-insensitive (RGSi) G aq chimeras. RGS insensitivity was determined by these mutants’ inability to recruit RGS2-EGFP from the nucleus of HEK293 cells to the plasma membrane despite additional mutations that render constitutive activity. Recovery from Ik(so) inhibition mediated by RGSi mutants was 5-fold slower than their wild type counterparts, confirming the necessity of native RGS proteins for rapid termination of G aq mediated signals. In addition to regulating decay of EPSPs, evidence suggests RGS proteins control activation kinetics of G-protein-mediated signals by undetermined mechanisms. We therefore hypothesized that native RGS proteins regulate onset kinetics by acting as physical scaffolds to increase the availability of activated receptors to inactive G aq, bypassing cellular diffusional limitations. Fluorescence recovery after photobleaching (FRAP) was used to determine the diffusional mobility of G aq signaling components in the presence or absence of extracellular crosslinking reagents. Even though M3R recruited RGS2-EGFP to the plasma membrane in HEK293 cells, interaction between these two proteins was extremely transient, as RGS2-EGFP diffusion was unaltered upon immobilization of ECFP-M3R. In addition, G aq-EGFP constrained diffusion when interacting with ECFP-M3R was not further slowed by RGS2 expression. Finally, RGS proteins may act as kinetic scaffolds whereby RGS-accelerated GAP activity leads to multiple rounds of activation/inactivation per receptor-Gaq binding event. A mutation causing increased intrinsic GTPase activity of G aq significantly restored onset rates of G aq activation ( I k (s o > inhibition) in the background of RGS-insensitivity. These results indicate a minimal physical scaffolding function of RGS2 and provide evidence for native RGS protein-mediated kinetic scaffolding contributing to fast G aq activation kinetics observed in CGNs.